AI MARKET SCANNING

$ABVX.PA

ABIVAX

FranceFRANCE
FREE PREVIEW
📅 Next Earnings: Sep 21, 2026 🌙 Close🌐 Website🏛️ Euronext Paris📁 Healthcare🏭 Biotechnology
AVG HISTORICAL GAP-2.03%
MAX GAP RECORD-6.03%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $ABVX.PA

EXECUTIONS1 LOGS
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
2026-09-08QUANT ALGOSELL x5$•••.•• → $•••.••190m🔒 ENCRYPTED-5.08%
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL